Characteristics of IDH-mutant gliomas with non-canonical IDH mutation

被引：0

作者：

L. Poetsch

C. Bronnimann

H. Loiseau

J. S. Frénel

A. Siegfried

R. Seizeur

G. Gauchotte

D. Cappellen

C. Carpentier

D. Figarella-Branger

S. Eimer

D. Meyronet

F. Ducray

机构：

[1] Service d’Oncologie Médicale,Neuro

[2] CHU de Bordeaux- Hôpital Saint André,oncology Department

[3] Service de Neurochirurgie B,undefined

[4] CHU de Bordeaux - Hôpital Pellegrin,undefined

[5] EA 7435 – IMOTION (Imagerie moléculaire et thérapies innovantes en oncologie) Université de Bordeaux,undefined

[6] Institut de Cancérologie de l’Ouest,undefined

[7] Centre René Gauducheau,undefined

[8] Service de Pathologie,undefined

[9] Institut Universitaire du Cancer de Toulouse Oncopole,undefined

[10] Service de Neurochirurgie,undefined

[11] Hôpital de la Cavale Blanche,undefined

[12] CHRU de Brest,undefined

[13] Université de Brest,undefined

[14] Service d’Anatomie et Cytologie Pathologiques,undefined

[15] CRB BB-0033-00035,undefined

[16] CHRU de Nancy,undefined

[17] INSERM U1256,undefined

[18] Université de Lorraine,undefined

[19] U1035 Inserm - Biothérapie des Maladies Génétiques,undefined

[20] Inflammatoires et Cancers (BMGIC),undefined

[21] Univ. Bordeaux,undefined

[22] Service de Biologie des Tumeurs,undefined

[23] CHU de Bordeaux - Hôpital du Haut Lévêque,undefined

[24] AP-HP,undefined

[25] Hôpitaux Universitaires La Pitié Salpêtrière - Charles Foix,undefined

[26] Service de Neurologie 2-Mazarin,undefined

[27] Sorbonne Université,undefined

[28] Inserm,undefined

[29] CNRS,undefined

[30] UMR S 1127,undefined

[31] Institut du Cerveau et de la Moelle Epiniere,undefined

[32] ICM,undefined

[33] Aix-Marseille Univ,undefined

[34] APHM,undefined

[35] CNRS,undefined

[36] INP,undefined

[37] Inst Neurophysiopathol,undefined

[38] CHU Timone,undefined

[39] Service d’Anatomie Pathologique et de Neuropathologie,undefined

[40] Service de Pathologie,undefined

[41] CHU de Bordeaux,undefined

[42] Hôpital Pellegrin,undefined

[43] Centre de Recherche en Cancérologie de Lyon,undefined

[44] INSERM U1052,undefined

[45] CNRS UMR 5286,undefined

[46] Cancer Cell Plasticity department,undefined

[47] Université Claude Bernard Lyon 1,undefined

[48] Hospices Civils de Lyon,undefined

来源：

Journal of Neuro-Oncology | 2021年 / 151卷

关键词：

Non-canonical IDH mutant gliomas; Inherited predisposition to cancer; Infra-tentorial gliomas; Multicentric gliomas;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：279 / 286

页数：7

共 50 条

[31] TRANSCRIPTIONAL AND CHROMATIN-ACCESSIBILITY HETEROGENEITY IN IDH-MUTANT GLIOMAS
Lyne, Anne-Marie
Ducray, Francois
Cavalli, Florence
NEURO-ONCOLOGY, 2022, 24 : 116 - 116
[32] IDH-Mutant Gliomas Trigger Signaling Events in Choroid Plexus
Sadegh, Cameron
Benedict, Michaela
Lee, Christine K.
Cahill, Daniel P.
Lehtinen, Maria K.
NEUROSURGERY, 2020, 67 : 312 - 313
[33] INCIDENCE OF PSEUDOPROGRESSION IN HIGH-GRADE IDH-MUTANT GLIOMAS
Seyve, A.
Cartalat, S.
Meyronet, D.
D'hombres, A.
Barritault, M.
Jouanneau, E.
Berhouma, M.
Guyotat, J.
Honnorat, J.
Ducray, F.
NEURO-ONCOLOGY, 2019, 21 : 69 - 69
[34] DNA damage in IDH-mutant gliomas: mechanisms and clinical implications
Shi, Diana D.
Anand, Soummitra
Abdullah, Kalil G.
McBrayer, Samuel K.
JOURNAL OF NEURO-ONCOLOGY, 2023, 162 (03) : 515 - 523
[35] CLINICAL, PATHOLOGICAL, AND GENOMIC FEATURES OF INFRATENTORIAL IDH-MUTANT GLIOMAS
Wang, L.
NEURO-ONCOLOGY, 2024, 26 : V118 - V118
[36] Oncogenic KRAS hotspot mutations are rare in IDH-mutant gliomas
Schittenhelm, Jens
Krischker, Nadin
Gepfner-Tuma, Irina
Behling, Felix
Noell, Susan
Eckert, Franziska
Biskup, Saskia
Tabatabai, Ghazaleh
BRAIN PATHOLOGY, 2019, 29 (03) : 321 - 324
[37] DNA damage in IDH-mutant gliomas: mechanisms and clinical implications
Diana D. Shi
Soummitra Anand
Kalil G. Abdullah
Samuel K. McBrayer
Journal of Neuro-Oncology, 2023, 162 : 515 - 523
[38] Prognostic value of integrative genomic approaches for IDH-mutant gliomas
Gallo, Marco
NEURO-ONCOLOGY, 2023, 25 (11) : 2042 - 2043
[39] Secondary IDH-mutant gliosarcoma in a patient with prior IDH-mutant grade 2 astrocytoma
Nyabuto, Elizabeth
Fenstermaker, Robert A.
Qiu, Jingxin
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2024,
[40] MUTANT IDH INHIBITORS INDUCE LINEAGE DIFFERENTIATION IN IDH-MUTANT OLIGODENDROGLIOMA
Spitzer, Avishay
Gritsch, Simon
Weisman, Hannah R.
Castro, L. Nicolas Gonzalez
Chanoch, Rony
Lee, Christine K.
Nagashima, Hiroaki
Miller, Julie J.
Arrillaga-Romany, Isabel
Louis, David N.
Wakimoto, Hiroaki
Pisano, Will
Wen, Patrick Y.
Ligon, Keith L.
Cahill, Daniel P.
Suva, Mario L.
Tirosh, Itay
NEURO-ONCOLOGY, 2021, 23 : 230 - 230

← 1 2 3 4 5 →